ROIVHealthcareLarge-Cap
Roivant Sciences Ltd. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Roivant Sciences Ltd. (ROIV), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are ROIV insiders buying or selling?
Roivant Sciences Ltd. insiders reported 2 open-market buys ($20.2M) and 134 sells ($2.1B) across 136 Form 4 filings — a net selling position of $2.1B.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 2, 2026)
Total Form 4 filings
136
SEC EDGAR
Insider filers
18
Insider buys (2)
$20.2M
Insider sells (134)
$2.1B
Insider sentiment
Net sellingNet insider flow of $2.1B in net selling.
Recent ROIV insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Meghan Fitzgerald | Director | Sale | 10.0K | $34.90 | $349.0K |
| Jul 1, 2026 | Melissa B, Epperly | Director | Sale | 17.8K | $34.38 | $610.3K |
| Jul 1, 2026 | Keith S Manchester | Director | Sale | 1.6M | $34.46 | $56.4M |
| Jul 1, 2026 | Daniel Allen Gold | Director | Sale | 1.4M | $34.32 | $49.4M |
| Jun 30, 2026 | QVT Financial LP | Other | Sale | 1.4M | $34.32 | $49.4M |
| Jun 29, 2026 | Mayukh Sukhatme | President & CIO | Sale | 1.0M | $34.11 | $34.1M |
| Jun 26, 2026 | Eric Venker | President & Immunovant CEO | Sale | 200.0K | $33.16 | $6.6M |
| May 22, 2026 | Eric Venker | President & Immunovant CEO | Sale | 200.0K | $30.27 | $6.1M |
| Apr 22, 2026 | Eric Venker | President & Immunovant CEO | Sale | 200.0K | $29.59 | $5.9M |
| Apr 20, 2026 | Matthew Gline | CEO | Sale | 289.8K | $29.16 | $8.4M |
| Apr 10, 2026 | Jennifer Humes | Chief Accounting Officer | Sale | 13.5K | $28.37 | $384.1K |
| Mar 31, 2026 | Meghan Fitzgerald | Director | Sale | 70.0K | $27.45 | $1.9M |
| Mar 19, 2026 | Eric Venker | President & Immunovant CEO | Sale | 200.0K | $28.24 | $5.6M |
| Mar 18, 2026 | Melissa B, Epperly | Director | Sale | 41.9K | $28.68 | $1.2M |
| Feb 24, 2026 | Frank Torti | President and Vant Chair | Sale | 3.0M | $27.35 | $82.0M |
| Feb 18, 2026 | Eric Venker | President & Immunovant CEO | Sale | 200.0K | $26.49 | $5.3M |
| Feb 14, 2026 | Keith S Manchester | Director | Sale | 1.2M | $26.64 | $32.7M |
| Feb 14, 2026 | Daniel Allen Gold | Director | Sale | 1.2M | $26.64 | $32.7M |
| Feb 14, 2026 | QVT Financial LP | Other | Sale | 1.2M | $26.64 | $32.7M |
| Feb 11, 2026 | Mayukh Sukhatme | President & CIO | Sale | 339.4K | $26.47 | $9.0M |
| Jan 15, 2026 | Eric Venker | President & Immunovant CEO | Sale | 200.0K | $21.92 | $4.4M |
| Jan 1, 2026 | Mayukh Sukhatme | President & CIO | Sale | 1.3M | $21.72 | $28.9M |
| Dec 30, 2025 | Richard Pulik | CFO | Sale | 406.7K | $22.43 | $9.1M |
| Dec 30, 2025 | Eric Venker | President & Immunovant CEO | Sale | 275.0K | $22.47 | $6.2M |
| Dec 20, 2025 | Mayukh Sukhatme | President & CIO | Sale | 26.8K | $23.09 | $619.5K |
Showing the 25 most recent of 136 Form 4 filings for Roivant Sciences Ltd..
Most active ROIV insiders
- Eric Venker52 filings
- Rakhi Kumar20 filings
- Matthew Gline14 filings
- Daniel Allen Gold7 filings
- Keith S Manchester7 filings
Ask anything about ROIV insider activity
Use Trabud's AI agent to query Roivant Sciences Ltd.'s Form 4 history in plain English — "Show me ROIV CEO purchases this year" or compare it against any other ticker.
Open the AI agentROIV insider trading FAQ
Are Roivant Sciences Ltd. insiders buying or selling?
Across 136 SEC Form 4 filings, Roivant Sciences Ltd. (ROIV) insiders reported 2 open-market purchases totaling $20.2M and 134 sales totaling $2.1B. That is a net selling position of $2.1B.
How many insiders trade ROIV stock?
18 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Roivant Sciences Ltd.. The most recent filing was accepted on Jul 2, 2026.
Where does Trabud get ROIV insider trading data?
All ROIV insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.